Pages that link to "Q71974485"
Jump to navigation
Jump to search
The following pages link to Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD (Q71974485):
Displaying 50 items.
- Biocompatible dialysis fluids for peritoneal dialysis (Q24197836) (← links)
- Biocompatible dialysis fluids for peritoneal dialysis (Q24240521) (← links)
- Glycosylation of uroplakins. Implications for bladder physiopathology (Q26823952) (← links)
- Glycated albumin: an overview of the In Vitro models of an In Vivo potential disease marker (Q27012452) (← links)
- Intercellular localization of occludins and ZO-1 as a solute transport barrier of the mesothelial monolayer (Q33266680) (← links)
- Rationale and design of the balANZ trial: A randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function (Q33693392) (← links)
- Peritoneal dialysis (Q33718889) (← links)
- The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both? (Q34159870) (← links)
- Mucositis and salivary antioxidants in patients undergoing bone marrow transplantation (BMT) (Q34317762) (← links)
- Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study (Q34725172) (← links)
- Encapsulating peritoneal sclerosis-a rare but devastating peritoneal disease. (Q34816520) (← links)
- The solution to better preservation of the peritoneal membrane still lies hidden in the solution (Q35524650) (← links)
- Treatment of severe ultrafiltration failure with nonglucose dialysis solutions in patients with and without peritoneal sclerosis (Q35573614) (← links)
- Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease (Q36152748) (← links)
- Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes? (Q36249065) (← links)
- The influence of initial peritoneal transport characteristics, inflammation, and high glucose exposure on prognosis for peritoneal membrane function (Q36474303) (← links)
- Time course of peritoneal function in automated and continuous peritoneal dialysis (Q36474329) (← links)
- “NEPP” Peritoneal Dialysis Regimen has Beneficial Effects on Plasma Cel and 3-DG, but not Pentosidine, CML, and MGO (Q36475512) (← links)
- Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions (Q36605072) (← links)
- Update on peritoneal dialysis solutions (Q36735424) (← links)
- Peri-aortic fat tissue thickness in peritoneal dialysis patients (Q36831518) (← links)
- Peritoneal damage by peritoneal dialysis solutions (Q37084541) (← links)
- Cardiovascular risk in the peritoneal dialysis patient (Q37766750) (← links)
- Protective measures against ultrafiltration failure in peritoneal dialysis patients (Q37970606) (← links)
- Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients (Q38006722) (← links)
- Peritoneal changes in patients on long-term peritoneal dialysis (Q38106610) (← links)
- The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients (Q38108697) (← links)
- Membrane nanotubes between peritoneal mesothelial cells: functional connectivity and crucial participation during inflammatory reactions (Q38266882) (← links)
- Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries (Q38434639) (← links)
- Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology (Q38528380) (← links)
- Factors increasing severity of peritonitis in long-term peritoneal dialysis patients. (Q39339077) (← links)
- Epigallocatechin gallate suppresses peritoneal fibrosis in mice (Q42723719) (← links)
- Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment. (Q43468862) (← links)
- Advanced glycation end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio (Q44438637) (← links)
- Glucose degradation products (GDP) retard remesothelialization independently of d-glucose concentration (Q44609815) (← links)
- Peritoneal dialysis: diabetes of the peritoneal cavity (Q44649164) (← links)
- Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis (Q44785207) (← links)
- Prevention and treatment of peritoneal dialysis membrane failure (Q47756763) (← links)
- Stability of the peritoneal membrane in long-term peritoneal dialysis patients (Q47756792) (← links)
- Accumulation of advanced glycation end products and beta 2-microglobulin in fibrotic thickening of the peritoneum in long-term peritoneal dialysis patients. (Q54441131) (← links)
- Biocompatible dialysis fluids for peritoneal dialysis (Q58605486) (← links)
- Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia (Q73783931) (← links)
- Evaluation of ultrafiltration failure (Q74827282) (← links)
- Present status of CAPD in Japan (Q77108051) (← links)
- Growth factors VEGF and TGF-beta1 in peritoneal dialysis (Q78115905) (← links)
- Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model (Q79453283) (← links)
- Accelerated senescence of human peritoneal mesothelial cells exposed to high glucose: the role of TGF-beta1 (Q79767208) (← links)
- 3-Deoxygalactosone, a new glucose degradation product in peritoneal dialysis fluids: Identification, quantification by HPLC/DAD/MSMS and its pathway of formation (Q82770942) (← links)
- Recommendations for pathological diagnosis on biopsy samples from peritoneal dialysis patients (Q92617913) (← links)
- Encapsulating peritoneal sclerosis: the state of affairs (Q95361164) (← links)